Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
First Busey Corp
BUSE
$2.58B
| $17.5M | 0.02% |
937,833
-111,792
| -11% | -$1.94M |
|
902
Canadian Natural Resources
CNQ
$98.1B
| $17.4M | 0.02% |
2,047,309
+1,396,115
| +214% | +$11.3M |
|
903
SLM Corp
SLM
$5.26B
| $17.3M | 0.02% |
2,463,700
+1,016,300
| +70% | +$7.6M |
|
|
NUAN
904
DELISTED
Nuance Communications, Inc.
NUAN
| $17.3M | 0.01% |
684,355
-2,195,100
| -76% | -$45.8M |
|
|
NTUS
905
DELISTED
Natus Medical Inc
NTUS
| $17.3M | 0.01% |
791,817
+262,372
| +50% | +$6.01M |
|
906
Neurogene
NGNE
$740M
| $17.3M | 0.01% |
52,015
+9,660
| +23% | +$2.52M |
|
|
SLCA
907
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $17.2M | 0.01% |
4,778,212
+1,440,500
| +43% | +$3.64M |
|
|
FSP
908
Franklin Street Properties
FSP
$46.3M
| $17.2M | 0.01% |
3,388,297
-373,800
| -10% | -$1.98M |
|
909
Huron Consulting
HURN
$2.39B
| $17.2M | 0.01% |
388,758
-27,000
| -6% | -$1.22M |
|
910
Flowserve
FLS
$10.3B
| $17.2M | 0.01% |
602,300
-244,600
| -29% | -$6.53M |
|
911
MGE Energy Inc
MGEE
$3.07B
| $17.2M | 0.01% |
266,194
-179,800
| -40% | -$11.7M |
|
|
BKI
912
DELISTED
Black Knight, Inc. Common Stock
BKI
| $17.2M | 0.01% |
236,478
+201,378
| +574% | +$14.3M |
|
913
Insperity
NSP
$1.92B
| $17.1M | 0.01% |
+264,200
| New | +$13.2M |
|
|
ADAP
914
DELISTED
Adaptimmune Therapeutics
ADAP
| $17.1M | 0.01% |
1,705,411
-44,549
| -3% | -$280K |
|
915
DXC Technology
DXC
$1.71B
| $17.1M | 0.01% |
1,034,300
+622,235
| +151% | +$9.9M |
|
916
Howard Hughes
HHH
$3.98B
| $17M | 0.01% |
343,967
+141,030
| +69% | +$7.1M |
|
917
Helmerich & Payne
HP
$4.29B
| $17M | 0.01% |
871,500
-606,775
| -41% | -$11.8M |
|
918
Silicon Laboratories
SLAB
$7.3B
| $17M | 0.01% |
169,398
+108,500
| +178% | +$10.1M |
|
919
Sun Life Financial
SLF
$44.4B
| $17M | 0.01% |
462,199
-247,300
| -35% | -$8.5M |
|
920
Alpha Pro Tech
APT
$54.8M
| $17M | 0.01% |
958,716
-81,400
| -8% | -$1.12M |
|
921
AGCO
AGCO
$7.11B
| $16.9M | 0.01% |
304,000
+161,900
| +114% | +$8.44M |
|
|
CUK
922
DELISTED
Carnival PLC
CUK
| $16.9M | 0.01% |
1,339,763
+684,736
| +105% | +$8.86M |
|
923
Ooma
OOMA
$553M
| $16.8M | 0.01% |
1,022,003
+107,200
| +12% | +$1.34M |
|
924
Par Pacific Holdings
PARR
$4.12B
| $16.8M | 0.01% |
1,868,887
-709,400
| -28% | -$6.11M |
|
|
DHIL
925
DELISTED
Diamond Hill
DHIL
| $16.8M | 0.01% |
147,581
+1,100
| +0.8% | +$115K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.